BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 23, Issue 46
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (9886)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-6) series.
Item 
Count 
PDF583
WORD253
HTML3877
Figures (1-2)200
Tables (1-6)139
 Sum=5052
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1011
Download1150
 Sum=2161
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse925
Download1748
 Sum=2673
Dec 14, 2017 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Chen JM, Liu T, Gao S, Tong XD, Deng FH, Nie B. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China. World J Gastroenterol 2017; 23(46): 8235-8247 [PMID: 29290660 DOI: 10.3748/wjg.v23.i46.8235]
URL: https://www.wjgnet.com/1007-9327/full/v23/i46/8235.htm
Number Citing Articles
1
Friederike Cordes, Claudia Demmig, Arne Bokemeyer, Markus Brückner, Frank Lenze, Philipp Lenz, Tobias Nowacki, Phil Tepasse, Hartmut H. Schmidt, M. Alexander Schmidt, Christoph Cichon, Dominik Bettenworth. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease. Clinical and Translational Gastroenterology 2020; 11(3): e00134 doi: 10.14309/ctg.0000000000000134
2
Nader D Daoud, Jana G Hashash, Michael F Picco, Francis A Farraye. Faecal Calprotectin from Ileostomy Output Is Sensitive and Specific for the Prediction of Small Bowel Inflammation in Patients with Crohn’s Disease. Journal of Crohn's and Colitis 2022; 16(4): 601 doi: 10.1093/ecco-jcc/jjab182
3
Tomoya Sugiyama, Makoto Sasaki, Shoko Nakagawa, Satoshi Inoue, Kazunori Adachi, Takashi Yoshimine, Yoshiharu Yamaguchi, Yasuhiro Tamura, Shinya Izawa, Yasutaka Hijikata, Masahide Ebi, Mari Mizuno, Sayuri Yamamoto, Yasushi Funaki, Naotaka Ogasawara, Chiho Goto, Kunio Kasugai. The association among enterobacterial flora, dietary factors, and prognosis in patients with ulcerative colitis. Journal of Clinical Biochemistry and Nutrition 2020; 66(2): 152 doi: 10.3164/jcbn.19-90
4
Dora Grgić, Karlo Golubić, Marko Brinar, Željko Krznarić. Predictive value of faecal calprotectin in ulcerative colitis – single centre experience. Annals of Medicine 2022; 54(1): 1570 doi: 10.1080/07853890.2022.2082518
5
Giulia D'Arcangelo, Salvatore Oliva, Anna Dilillo, Franca Viola, Fortunata Civitelli, Sara Isoldi, Salvatore Cucchiara, Marina Aloi. Predictors of Long‐term Clinical and Endoscopic Remission in Children With Crohn Disease Treated With Infliximab. Journal of Pediatric Gastroenterology and Nutrition 2019; 68(6): 841 doi: 10.1097/MPG.0000000000002262
6
Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke, Katarzyna Neubauer. Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults. Diagnostics 2020; 10(6): 367 doi: 10.3390/diagnostics10060367
7
Robert Battat, William J. Sandborn. Advances in the Comprehensive Management of Postoperative Crohn’s Disease. Clinical Gastroenterology and Hepatology 2022; 20(7): 1436 doi: 10.1016/j.cgh.2021.03.048
8
Klaus R. Herrlinger, Eduard F. Stange. To STRIDE or not to STRIDE: a critique of “treat to target” in Crohn´s disease. Expert Review of Gastroenterology & Hepatology 2023; 17(12): 1205 doi: 10.1080/17474124.2023.2296564
9
Jun Kato, Takeichi Yoshida, Sakiko Hiraoka. Prediction of treatment outcome and relapse in inflammatory bowel disease. Expert Review of Clinical Immunology 2019; 15(6): 667 doi: 10.1080/1744666X.2019.1593140
10
Ashish R Srinivasan. Treat to target in Crohn’s disease: A practical guide for clinicians. World Journal of Gastroenterology 2024; 30(1): 50-69 doi: 10.3748/wjg.v30.i1.50
11
Lorenzo Bertani, Maria Gloria Mumolo, Gherardo Tapete, Eleonora Albano, Giovanni Baiano Svizzero, Federico Zanzi, Linda Ceccarelli, Massimo Bellini, Santino Marchi, Francesco Costa. Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment. European Journal of Gastroenterology & Hepatology 2020; 32(9): 1091 doi: 10.1097/MEG.0000000000001731
12
Mariusz A. Bromke, Katarzyna Neubauer, Radosław Kempiński, Małgorzata Krzystek-Korpacka. Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis. Journal of Clinical Medicine 2021; 10(10): 2203 doi: 10.3390/jcm10102203
13
Cong Dai, Min Jiang, Ming-Jun Sun. Fecal markers in the management of inflammatory bowel disease. Postgraduate Medicine 2018; 130(7): 597 doi: 10.1080/00325481.2018.1503919
14
Lina María Martínez-López, Alexis Perez-Gonzalez, Elizabeth Ann Washington, Andrew P. Woodward, Alexandra Jazmin Roth-Schulze, Julien R. S. Dandrieux, Thurid Johnstone, Nathalee Prakash, Aaron Jex, Caroline Mansfield, Franck Carbonero. Hierarchical modelling of immunoglobulin coated bacteria in dogs with chronic enteropathy shows reduction in coating with disease remission but marked inter-individual and treatment-response variability. PLOS ONE 2021; 16(8): e0255012 doi: 10.1371/journal.pone.0255012
15
Joel Tan Joel Tan, Teresa Neeman, Kavitha Subramaniam Kavitha Subramaniam. The utility of serum anti-tumour necrosis factor levels and biomarkers in predicting endoscopic activity in inflammatory bowel disease. Gastroenterology & Hepatology: Open Access 2022; 13(2): 53 doi: 10.15406/ghoa.2022.13.00494
16
Anuj Bohra, Ghada Mohamed, Abhinav Vasudevan, Diana Lewis, Daniel R. Van Langenberg, Jonathan P. Segal. The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn’s Disease: A Systematic Review and Meta-Analysis. Biomedicines 2023; 11(5): 1408 doi: 10.3390/biomedicines11051408
17
Maria Gloria Mumolo, Lorenzo Bertani, Linda Ceccarelli, Gabriella Laino, Giorgia Di Fluri, Eleonora Albano, Gherardo Tapete, Francesco Costa. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. World Journal of Gastroenterology 2018; 24(33): 3681-3694 doi: 10.3748/wjg.v24.i33.3681
18
Dan Turner, Amanda Ricciuto, Ayanna Lewis, Ferdinando D’Amico, Jasbir Dhaliwal, Anne M. Griffiths, Dominik Bettenworth, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Jürgen Schölmerich, Willem Bemelman, Silvio Danese, Jean Yves Mary, David Rubin, Jean-Frederic Colombel, Laurent Peyrin-Biroulet, Iris Dotan, Maria T. Abreu, Axel Dignass. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology 2021; 160(5): 1570 doi: 10.1053/j.gastro.2020.12.031
19
Kun He, Dong Wu. The treatment principles and targets for intestinal Behcet’s disease. Therapeutic Advances in Gastroenterology 2023; 16: 175628482311672 doi: 10.1177/17562848231167283
20
Jingwen Pei, Guobing Wang, Yi Li, Lan Li, Chang Li, Yu Wu, Jinbo Liu, Gang Tian. Utility of four machine learning approaches for identifying ulcerative colitis and Crohn's disease. Heliyon 2024; 10(1): e23439 doi: 10.1016/j.heliyon.2023.e23439
21
Meng-Hui Zhang, Han Wang, Hong-Gang Wang, Xin Wen, Xiao-Zhong Yang. Effective immune-inflammation index for ulcerative colitis and activity assessments. World Journal of Clinical Cases 2021; 9(2): 334-343 doi: 10.12998/wjcc.v9.i2.334
22
Lidia Neamți, Tudor Drugan, Cristina Drugan, Ciprian Silaghi, Lidia Ciobanu, Alexandra Crăciun. An Improved Score for the Evaluation of Mucosal Healing in Inflammatory Bowel Disease—A Pilot Study. Journal of Clinical Medicine 2023; 12(4): 1663 doi: 10.3390/jcm12041663
23
Qingyang Zhou, Qingli Zhu, Wei Liu, Wenbo Li, Li Ma, Mengsu Xiao, Jingjuan Liu, Hong Yang, Jiaming Qian. New score models for assessing disease activity in Crohn's disease based on bowel ultrasound and biomarkers: Ideal surrogates for endoscopy or imaging. Clinical and Translational Science 2023; 16(9): 1639 doi: 10.1111/cts.13575
24
Katarzyna Akutko, Barbara Iwańczak. Evaluation of Fecal Calprotectin, Serum C-Reactive Protein, Erythrocyte Sedimentation Rate, Seromucoid and Procalcitonin in the Diagnostics and Monitoring of Crohn’s Disease in Children. Journal of Clinical Medicine 2022; 11(20): 6086 doi: 10.3390/jcm11206086
25
Bailu Geng, Xueli Ding, Xiaoyu Li, Hua Liu, Wenjun Zhao, Haihong Gong, Zibin Tian, Jing Guo. Peripheral blood T-lymphocyte subsets are potential biomarkers of disease severity and clinical outcomes in patients with ulcerative colitis: a retrospective study. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02769-5
26
Min Zhu, Jing-Xi Mu, Ming-Shan Jiang, Arjudeb Mukherjee, Zhen Zeng, Yi-Ding Chen, Xiao-Li Yang, Hu Zhang. Chinese research into ulcerative colitis from 1978 to 2017: A bibliometric analysis. World Journal of Meta-Analysis 2020; 8(2): 163-172 doi: 10.13105/wjma.v8.i2.163
27
Parambir S. Dulai, Robert Battat, Maria Barsky, Nghia H. Nguyen, Christopher Ma, Neeraj Narula, Mahmoud Mosli, Niels Vande Casteele, Brigid S. Boland, Larry Prokop, M. Hassan Murad, Geert D'Haens, Brian G. Feagan, William J. Sandborn, Vipul Jairath, Siddharth Singh. Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors. American Journal of Gastroenterology 2020; 115(6): 885 doi: 10.14309/ajg.0000000000000596
28
Sophie Restellini, Che-Yung Chao, Myriam Martel, Alan Barkun, Omar Kherad, Ernest Seidman, Gary Wild, Alain Bitton, Waqqas Afif, Talat Bessissow, Peter L. Lakatos. Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis: A Systematic Review. Clinical Gastroenterology and Hepatology 2019; 17(7): 1265 doi: 10.1016/j.cgh.2018.12.021
29
Eran Zittan, Ian M. Gralnek, Marc S. Berns. The New Proactive Approach and Precision Medicine in Crohn’s Disease. Biomedicines 2020; 8(7): 193 doi: 10.3390/biomedicines8070193
30
Anna Luisa Bathe, Eirini Mavropoulou, Nicolae-Catalin Mechie, Golo Petzold, Volker Ellenrieder, Steffen Kunsch, Ahmad Amanzada, Bruno Bonaz. Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn’s disease and ulcerative colitis. PLOS ONE 2019; 14(10): e0223893 doi: 10.1371/journal.pone.0223893
31
Marco Daperno, Alessandro Armuzzi, Silvio Danese, Walter Fries, Giuseppina Liguori, Ambrogio Orlando, Claudio Papi, Mariabeatrice Principi, Fernando Rizzello, Angelo Viscido, Paolo Gionchetti. Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/3108025
32
Timna Naftali, Adi Eindor-Abarbanel, Nahum Ruhimovich, Ariella Bar-Gil Shitrit, Fabiana Sklerovsky-Benjaminov, Fred Konikoff, Shay Matalon, Haim Shirin, Yael Milgrom, Tomer Ziv-Baran, Efrat Broide. The Relationship between Gender, Severity of Disease, Treatment Type, and Employment Outcome in Patients with Inflammatory Bowel Disease in Israel. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/5090849
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345